14. Juni 2024 – On 7 June 2024 the Federal Council ratified Swissmedic’s 2023 reporting and approved the Annual Report. In addition to performance and financial overviews, this includes information about the wide-ranging activities of the Swiss Agency for Therapeutic Products. Swissmedic successfully completed the first year in the new 2023–2026 strategy period.

For more information, see here.